UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $94,000 | +9.3% | 4,829 | +1.5% | 0.00% | – |
| Q4 2020 | $86,000 | -61.3% | 4,758 | -58.7% | 0.00% | – |
| Q3 2020 | $222,000 | -24.5% | 11,512 | +2.1% | 0.00% | -100.0% |
| Q2 2020 | $294,000 | +182.7% | 11,274 | +93.9% | 0.00% | 0.0% |
| Q1 2020 | $104,000 | -44.4% | 5,814 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $187,000 | +34.5% | 5,616 | -3.7% | 0.00% | 0.0% |
| Q3 2019 | $139,000 | -33.5% | 5,832 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $209,000 | +26.7% | 5,813 | +30.1% | 0.00% | 0.0% |
| Q1 2019 | $165,000 | -12.2% | 4,468 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $188,000 | +16.0% | 4,364 | +27.6% | 0.00% | 0.0% |
| Q3 2018 | $162,000 | +1.2% | 3,420 | +6.1% | 0.00% | 0.0% |
| Q2 2018 | $160,000 | +6.7% | 3,224 | +6.5% | 0.00% | 0.0% |
| Q1 2018 | $150,000 | +42.9% | 3,026 | +7.2% | 0.00% | 0.0% |
| Q4 2017 | $105,000 | – | 2,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |